Skip to main content
Erschienen in: Virchows Archiv 1/2018

07.03.2018 | Original Article

Cathepsin K expression in clear cell “sugar” tumor (PEComa) of the lung

verfasst von: Anna Caliò, Maria Cecilia Mengoli, Alberto Cavazza, Giulio Rossi, Claudio Ghimenton, Matteo Brunelli, Maurizio Pea, Marco Chilosi, Lisa Marcolini, Guido Martignoni

Erschienen in: Virchows Archiv | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Clear cell “sugar” tumor is a rare benign neoplasm arising in the lung, considered as a part of the PEComa family. As PEComas of other sites, this tumor expresses melanocytic markers such as HMB45 and Melan-A. Despite cathepsin K, MITF and CD68 staining are known to be positive in a large number of PEComas and TFE3 rearrangement has been reported in a subset of PEComas, no data is available regarding the expression of these markers and the occurrence of TFE3 and TFEB rearrangement in clear cell “sugar” tumor of the lung. We have investigated the immunolabeling of cathepsin K, MITF, and CD68 in five cases of clear cell “sugar” tumor. Moreover, we have also sought the presence of TFE3 and TFEB rearrangement by fluorescence in situ hybridization (FISH) assay. In all tumors, strong immunoreactivity of cathepsin K and CD68 (PG-M1 and KP1 clone) was demonstrated, whereas none of them labeled for MITF staining and showed TFE3 or TFEB rearrangement. These findings widen the immunohistochemical profile of clear cell “sugar” tumor providing useful new markers for challenging cases. The expression of lysosomal markers, such as cathepsin K and CD68, strengthens the hypothesis that this tumor is part of the PEComa family.
Literatur
1.
Zurück zum Zitat Bonetti F, Pea M, Martignoni G, Doglioni C, Zamboni G, Capelli P, Rimondi P, Andrion A (1994) Clear cell (“sugar”) tumor of the lung is a lesion strictly related to angiomyolipoma—the concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC). Pathology 26(3):230–236CrossRefPubMed Bonetti F, Pea M, Martignoni G, Doglioni C, Zamboni G, Capelli P, Rimondi P, Andrion A (1994) Clear cell (“sugar”) tumor of the lung is a lesion strictly related to angiomyolipoma—the concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC). Pathology 26(3):230–236CrossRefPubMed
2.
Zurück zum Zitat Gaffey MJ, Mills SE, Askin FB, Ross GW, Sale GE, Kulander BG, Visscher DW, Yousem SA, Colby TV (1990) Clear cell tumor of the lung. A clinicopathologic, immunohistochemical, and ultrastructural study of eight cases. Am J Surg Pathol 14(3):248–259CrossRefPubMed Gaffey MJ, Mills SE, Askin FB, Ross GW, Sale GE, Kulander BG, Visscher DW, Yousem SA, Colby TV (1990) Clear cell tumor of the lung. A clinicopathologic, immunohistochemical, and ultrastructural study of eight cases. Am J Surg Pathol 14(3):248–259CrossRefPubMed
3.
Zurück zum Zitat Gaffey MJ, Mills SE, Zarbo RJ, Weiss LM, Gown AM (1991) Clear cell tumor of the lung. Immunohistochemical and ultrastructural evidence of melanogenesis. Am J Surg Pathol 15(7):644–653CrossRefPubMed Gaffey MJ, Mills SE, Zarbo RJ, Weiss LM, Gown AM (1991) Clear cell tumor of the lung. Immunohistochemical and ultrastructural evidence of melanogenesis. Am J Surg Pathol 15(7):644–653CrossRefPubMed
5.
Zurück zum Zitat Martignoni G, Bonetti F, Chilosi M, Brunelli M, Segala D, Amin MB, Argani P, Eble JN, Gobbo S, Pea M (2012) Cathepsin K expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney. Modern Pathol : Off J US Can Acad Pathol Inc 25(1):100–111CrossRef Martignoni G, Bonetti F, Chilosi M, Brunelli M, Segala D, Amin MB, Argani P, Eble JN, Gobbo S, Pea M (2012) Cathepsin K expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney. Modern Pathol : Off J US Can Acad Pathol Inc 25(1):100–111CrossRef
6.
Zurück zum Zitat Caliò A, Brunelli M, Segala D, Pedron S, Tardanico R, Remo A, Gobbo S, Meneghelli E, Doglioni C, Hes O, Zampini C, Argani P, Martignoni G (2017) t(6;11) renal cell carcinoma: a study of 7 cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma. Mod Pathol in press Caliò A, Brunelli M, Segala D, Pedron S, Tardanico R, Remo A, Gobbo S, Meneghelli E, Doglioni C, Hes O, Zampini C, Argani P, Martignoni G (2017) t(6;11) renal cell carcinoma: a study of 7 cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma. Mod Pathol in press
7.
Zurück zum Zitat Motyckova G, Weilbaecher KN, Horstmann M, Rieman DJ, Fisher DZ, Fisher DE (2001) Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc Natl Acad Sci U S A 98(10):5798–5803CrossRefPubMedPubMedCentral Motyckova G, Weilbaecher KN, Horstmann M, Rieman DJ, Fisher DZ, Fisher DE (2001) Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc Natl Acad Sci U S A 98(10):5798–5803CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Argani P, Aulmann S, Illei PB, Netto GJ, Ro J, Cho HY, Dogan S, Ladanyi M, Martignoni G, Goldblum JR, Weiss SW (2010) A distinctive subset of PEComas harbors TFE3 gene fusions. Am J Surg Pathol 34(10):1395–1406CrossRefPubMed Argani P, Aulmann S, Illei PB, Netto GJ, Ro J, Cho HY, Dogan S, Ladanyi M, Martignoni G, Goldblum JR, Weiss SW (2010) A distinctive subset of PEComas harbors TFE3 gene fusions. Am J Surg Pathol 34(10):1395–1406CrossRefPubMed
9.
Zurück zum Zitat Tanaka M, Kato K, Gomi K, Matsumoto M, Kudo H, Shinkai M, Ohama Y, Kigasawa H, Tanaka Y (2009) Perivascular epithelioid cell tumor with SFPQ/PSF-TFE3 gene fusion in a patient with advanced neuroblastoma. Am J Surg Pathol 33(9):1416–1420CrossRefPubMed Tanaka M, Kato K, Gomi K, Matsumoto M, Kudo H, Shinkai M, Ohama Y, Kigasawa H, Tanaka Y (2009) Perivascular epithelioid cell tumor with SFPQ/PSF-TFE3 gene fusion in a patient with advanced neuroblastoma. Am J Surg Pathol 33(9):1416–1420CrossRefPubMed
10.
Zurück zum Zitat Ohe C, Kuroda N, Hes O, Michal M, Vanecek T, Grossmann P, Tanaka Y, Tanaka M, Inui H, Komai Y, Matsuda T, Uemura Y (2012) A renal epithelioid angiomyolipoma/perivascular epithelioid cell tumor with TFE3 gene break visualized by FISH. Med Mol Morphol 45(4):234–237CrossRefPubMed Ohe C, Kuroda N, Hes O, Michal M, Vanecek T, Grossmann P, Tanaka Y, Tanaka M, Inui H, Komai Y, Matsuda T, Uemura Y (2012) A renal epithelioid angiomyolipoma/perivascular epithelioid cell tumor with TFE3 gene break visualized by FISH. Med Mol Morphol 45(4):234–237CrossRefPubMed
11.
Zurück zum Zitat Lee SE, Choi YL, Cho J, Kim T, Song SY, Sung CO (2012) Ovarian perivascular epithelioid cell tumor not otherwise specified with transcription factor E3 gene rearrangement: a case report and review of the literature. Hum Pathol 43(7):1126–1130CrossRefPubMed Lee SE, Choi YL, Cho J, Kim T, Song SY, Sung CO (2012) Ovarian perivascular epithelioid cell tumor not otherwise specified with transcription factor E3 gene rearrangement: a case report and review of the literature. Hum Pathol 43(7):1126–1130CrossRefPubMed
12.
Zurück zum Zitat Lee M, Cho KJ, Yu C, Park Y, Kim JC, Kim J, Yu E, Kim MJ (2012) Perivascular epithelioid cell tumor of the sigmoid colon with transcription factor E3 expression. Ann Diagn Pathol 16(4):306–311CrossRefPubMed Lee M, Cho KJ, Yu C, Park Y, Kim JC, Kim J, Yu E, Kim MJ (2012) Perivascular epithelioid cell tumor of the sigmoid colon with transcription factor E3 expression. Ann Diagn Pathol 16(4):306–311CrossRefPubMed
13.
Zurück zum Zitat Kuroda N, Goda M, Kazakov DV, Hes O, Michal M, Lee GH (2009) Perivascular epithelioid cell tumor of the nasal cavity with TFE3 expression. Pathol Int 59(10):769–770CrossRefPubMed Kuroda N, Goda M, Kazakov DV, Hes O, Michal M, Lee GH (2009) Perivascular epithelioid cell tumor of the nasal cavity with TFE3 expression. Pathol Int 59(10):769–770CrossRefPubMed
14.
Zurück zum Zitat Malinowska I, Kwiatkowski DJ, Weiss S, Martignoni G, Netto G, Argani P (2012) Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas: further evidence for a biological distinction. Am J Surg Pathol 36(5):783–784CrossRefPubMedPubMedCentral Malinowska I, Kwiatkowski DJ, Weiss S, Martignoni G, Netto G, Argani P (2012) Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas: further evidence for a biological distinction. Am J Surg Pathol 36(5):783–784CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Cho HY, Chung DH, Khurana H, Zhai QJ, Ro JY (2008) The role of TFE3 in PEComa. Histopathology 53(2):236–249CrossRefPubMed Cho HY, Chung DH, Khurana H, Zhai QJ, Ro JY (2008) The role of TFE3 in PEComa. Histopathology 53(2):236–249CrossRefPubMed
16.
Zurück zum Zitat Williamson SR, Bunde PJ, Montironi R, Lopez-Beltran A, Zhang S, Wang M, Maclennan GT, Cheng L (2013) Malignant perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder with TFE3 gene rearrangement: clinicopathologic, immunohistochemical, and molecular features. Am J Surg Pathol 37(10):1619–1626CrossRefPubMed Williamson SR, Bunde PJ, Montironi R, Lopez-Beltran A, Zhang S, Wang M, Maclennan GT, Cheng L (2013) Malignant perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder with TFE3 gene rearrangement: clinicopathologic, immunohistochemical, and molecular features. Am J Surg Pathol 37(10):1619–1626CrossRefPubMed
17.
Zurück zum Zitat Rao Q, Cheng L, Xia QY, Liu B, Li L, Shi QL, Shi SS, Yu B, Zhang RS, Ma HH, Lu ZF, Tu P, Zhou XJ (2013) Cathepsin K expression in a wide spectrum of perivascular epithelioid cell neoplasms (PEComas): a clinicopathological study emphasizing extrarenal PEComas. Histopathology 62(4):642–650CrossRefPubMed Rao Q, Cheng L, Xia QY, Liu B, Li L, Shi QL, Shi SS, Yu B, Zhang RS, Ma HH, Lu ZF, Tu P, Zhou XJ (2013) Cathepsin K expression in a wide spectrum of perivascular epithelioid cell neoplasms (PEComas): a clinicopathological study emphasizing extrarenal PEComas. Histopathology 62(4):642–650CrossRefPubMed
18.
Zurück zum Zitat Chilosi M, Pea M, Martignoni G, Brunelli M, Gobbo S, Poletti V, Bonetti F (2009) Cathepsin-k expression in pulmonary lymphangioleiomyomatosis. Modern Pathol : Off J U S Can Acad Pathol Inc 22(2):161–166CrossRef Chilosi M, Pea M, Martignoni G, Brunelli M, Gobbo S, Poletti V, Bonetti F (2009) Cathepsin-k expression in pulmonary lymphangioleiomyomatosis. Modern Pathol : Off J U S Can Acad Pathol Inc 22(2):161–166CrossRef
19.
Zurück zum Zitat Martignoni G, Pea M, Reghellin D, Gobbo S, Zamboni G, Chilosi M, Bonetti F (2010) Molecular pathology of lymphangioleiomyomatosis and other perivascular epithelioid cell tumors. Arch Pathol Lab Med 134(1):33–40PubMed Martignoni G, Pea M, Reghellin D, Gobbo S, Zamboni G, Chilosi M, Bonetti F (2010) Molecular pathology of lymphangioleiomyomatosis and other perivascular epithelioid cell tumors. Arch Pathol Lab Med 134(1):33–40PubMed
20.
Zurück zum Zitat Krueger DA, Northrup H (2013) Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49(4):255–265CrossRefPubMedPubMedCentral Krueger DA, Northrup H (2013) Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49(4):255–265CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Liebow A, Castelman B (1963) Benign “clear cell tumors” of the lung. Am J Pathol 43:13–14 Liebow A, Castelman B (1963) Benign “clear cell tumors” of the lung. Am J Pathol 43:13–14
22.
Zurück zum Zitat Bonetti F, Pea M, Martignoni G, Zamboni G (1992) PEC and sugar. Am J Surg Pathol 16(3):307–308CrossRefPubMed Bonetti F, Pea M, Martignoni G, Zamboni G (1992) PEC and sugar. Am J Surg Pathol 16(3):307–308CrossRefPubMed
23.
Zurück zum Zitat Pea M, Bonetti F, Zamboni G, Martignoni G, Fiore-Donati L, Doglioni C (1991) Clear cell tumor and angiomyolipoma. Am J Surg Pathol 15(2):199–202CrossRefPubMed Pea M, Bonetti F, Zamboni G, Martignoni G, Fiore-Donati L, Doglioni C (1991) Clear cell tumor and angiomyolipoma. Am J Surg Pathol 15(2):199–202CrossRefPubMed
24.
Zurück zum Zitat Pea M, Martignoni G, Zamboni G, Bonetti F (1996) Perivascular epithelioid cell. Am J Surg Pathol 20(9):1149–1153CrossRefPubMed Pea M, Martignoni G, Zamboni G, Bonetti F (1996) Perivascular epithelioid cell. Am J Surg Pathol 20(9):1149–1153CrossRefPubMed
25.
Zurück zum Zitat Flieder DB, Travis WD (1997) Clear cell “sugar” tumor of the lung: association with lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in a patient with tuberous sclerosis. Am J Surg Pathol 21(10):1242–1247CrossRefPubMed Flieder DB, Travis WD (1997) Clear cell “sugar” tumor of the lung: association with lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in a patient with tuberous sclerosis. Am J Surg Pathol 21(10):1242–1247CrossRefPubMed
26.
Zurück zum Zitat Zheng G, Martignoni G, Antonescu C, Montgomery E, Eberhart C, Netto G, Taube J, Westra W, Epstein JI, Lotan T, Maitra A, Gabrielson E, Torbenson M, Iacobuzio-Donahue C, Demarzo A, Shih Ie M, Illei P, Wu TC, Argani P (2013) A broad survey of cathepsin K immunoreactivity in human neoplasms. Am J Clin Pathol 139(2):151–159CrossRefPubMedPubMedCentral Zheng G, Martignoni G, Antonescu C, Montgomery E, Eberhart C, Netto G, Taube J, Westra W, Epstein JI, Lotan T, Maitra A, Gabrielson E, Torbenson M, Iacobuzio-Donahue C, Demarzo A, Shih Ie M, Illei P, Wu TC, Argani P (2013) A broad survey of cathepsin K immunoreactivity in human neoplasms. Am J Clin Pathol 139(2):151–159CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Martignoni G, Pea M, Gobbo S, Brunelli M, Bonetti F, Segala D, Pan CC, Netto G, Doglioni C, Hes O, Argani P, Chilosi M (2009) Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas. Modern Pathology 22(8):1016–1022CrossRefPubMed Martignoni G, Pea M, Gobbo S, Brunelli M, Bonetti F, Segala D, Pan CC, Netto G, Doglioni C, Hes O, Argani P, Chilosi M (2009) Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas. Modern Pathology 22(8):1016–1022CrossRefPubMed
28.
Zurück zum Zitat Rapa I, Volante M, Cappia S, Rosas R, Scagliotti GV, Papotti M (2006) Cathepsin K is selectively expressed in the stroma of lung adenocarcinoma but not in bronchioloalveolar carcinoma. A useful marker of invasive growth. The American journal of clinical pathology 125(6):847–854CrossRefPubMed Rapa I, Volante M, Cappia S, Rosas R, Scagliotti GV, Papotti M (2006) Cathepsin K is selectively expressed in the stroma of lung adenocarcinoma but not in bronchioloalveolar carcinoma. A useful marker of invasive growth. The American journal of clinical pathology 125(6):847–854CrossRefPubMed
29.
Zurück zum Zitat Martignoni G, Pea M, Zampini C, Brunelli M, Segala D, Zamboni G, Bonetti F (2015) PEComas of the kidney and of the genitourinary tract. Seminars in diagnostic pathology 32(2):140–159CrossRefPubMed Martignoni G, Pea M, Zampini C, Brunelli M, Segala D, Zamboni G, Bonetti F (2015) PEComas of the kidney and of the genitourinary tract. Seminars in diagnostic pathology 32(2):140–159CrossRefPubMed
Metadaten
Titel
Cathepsin K expression in clear cell “sugar” tumor (PEComa) of the lung
verfasst von
Anna Caliò
Maria Cecilia Mengoli
Alberto Cavazza
Giulio Rossi
Claudio Ghimenton
Matteo Brunelli
Maurizio Pea
Marco Chilosi
Lisa Marcolini
Guido Martignoni
Publikationsdatum
07.03.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 1/2018
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-018-2325-1

Weitere Artikel der Ausgabe 1/2018

Virchows Archiv 1/2018 Zur Ausgabe

Neu im Fachgebiet Pathologie

Open Access 15.04.2024 | Biomarker | Schwerpunkt: Next Generation Pathology

Molekularpathologische Untersuchungen im Wandel der Zeit

11.04.2024 | Pathologie | Schwerpunkt: Next Generation Pathology

Vergleichende Pathologie in der onkologischen Forschung

Open Access 08.04.2024 | GIST | CME

Gastrointestinale Stromatumoren

Wo stehen wir?

03.04.2024 | Zielgerichtete Therapie | Schwerpunkt: Next Generation Pathology

Personalisierte Medizin in der Onkologie